BSE filing, NSE: AMANTA. Summary written from the filing by ALFA Finder's alert engine.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹170.90
- Market cap
- ₹663.6 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 45.2×Sector 48.7×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Management Change
Amanta Healthcare's COO Shri Anil Rathi resigned effective October 29, 2026. The departure is disclosed under Regulation 30 of the SEBI Listing Regulations.
Amanta Healthcare Other Announcement
Amanta Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Amanta Healthcare Promoter Selling (Off-Market)
Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare, disposed of 17,32,763 equity shares via an off-market gift. His stake decreased from 4.72% to 0.26%.
Amanta Healthcare Promoter Selling (Off-Market): ₹2.86 Cr
Promoter Pravinchandra Mehta sold 1,50,400 shares of Amanta Healthcare to fellow promoter Kirit Desai in an off-market inter-se transfer valued at ₹2.86 Crore.
- Value
- ₹2.86 Cr
Amanta Healthcare Promoter Buying (Off-Market): ₹2.86 Cr
Amanta Healthcare reported an inter-se off-market transfer of 1,50,400 equity shares between promoter group members. Kirit Ambalal Desai acquired the stake valued at ₹2.86 Crore from Pravinchandra Dhanjibhai Mehta.
- Value
- ₹2.86 Cr
- Promoter stake change
- +0.39%
Amanta Healthcare Promoter Buying (Off-Market): ₹5.72 Cr
Pravinchandra Dhanjibhai Mehta and Kirit Ambalal Desai, members of the promoter group, acquired 1,50,400 shares each via off-market inter-se transfers. Both transactions were valued at Rs. 2.86 Crore each.
- Value
- ₹5.72 Cr
- Promoter stake change
- +0.39%
Other board meeting date announcements
All →FCS Software Solutions Board Meeting Date
FCS Software Solutions intimated that its Board will meet on 4 Nov 2026. The agenda includes approval of unaudited H1/Q2 financial results.
EL Forge Board Meeting Date
El Forge Ltd scheduled a board meeting on November 7, 2026, to consider Q1 and H1 FY2027 results. Trading window stays closed until 48 hours post-disclosure.
Diffusion Engineers Board Meeting Date
Diffusion Engineers Ltd scheduled its board meeting for 4 November 2026 to approve Q1 FY27 unaudited financial results. Trading window reopens 48 hours post-declaration.
Veer Energy & Infrastructure Board Meeting Date
Veer Energy & Infrastructure Ltd intimated its Board meeting on 14 Nov 2026 to consider Q1/H1 results. Trading window reopens 17 Nov 2026.
M & B Engineering Board Meeting Date
M&B Engineering schedules a board meeting on 5 Nov 2026 to consider and approve unaudited financial results for Q1 and H1 FY27. No results or financial figures are disclosed in this intimation.
Allcargo Terminals Board Meeting Date
Allcargo Terminals scheduled a board meeting for 4 Nov 2026 to approve Q1/H1 FY27 financial results. The trading window remains closed until 6 Nov 2026.